Washington (AFP) | 19/04/2025 - 22:23:09 | US, Iran made 'very good progress' in nuclear talks: senior US official
Jerusalem (AFP) | 19/04/2025 - 21:50:29 | Israel campaign group calls for deal to return Gaza hostages after Netanyahu's comment
Jerusalem (AFP) | 19/04/2025 - 21:19:22 | Israeli PM says to return hostages without giving in to 'Hamas dictates'
Abuja (AFP) | 19/04/2025 - 21:11:30 | Gunmen kill dozens in central Nigeria: governor's office
Kyiv (AFP) | 19/04/2025 - 21:06:23 | Air-raid sirens sound in Kyiv despite Easter truce: AFP
Gaza City (AFP) | 19/04/2025 - 20:48:45 | Gaza rescuers say at least 54 killed in Israeli strikes Saturday
Jerusalem (AFP) | 19/04/2025 - 20:43:19 | Israel's Netanyahu vows to prevent Iran from acquiring nuclear arms
Kyiv (AFP) | 19/04/2025 - 20:30:04 | Zelensky says Ukraine will observe Easter ceasefire, accuses Russia of breaches
Kyiv (AFP) | 19/04/2025 - 20:23:04 | Ukraine governor reports Russian drone attacks, says 'not seeing any lull' amid Putin ceasefire
Kyiv (AFP) | 19/04/2025 - 20:19:27 | Ukraine issues air-raid warnings across east
AFP’s Global News Director, Phil Chetwynd, appeared on France 24’s Scoop on Friday, 7 February, to discuss artificial intelligence and its impact on journalism.
LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 and 2 trials at the 83rd American Academy of Dermatology (AAD) 2025 Annual Meeting.1 The presentation marks the third consecutive year that LEO Pharma has presented late-breaking data at AAD. Alongside this presentation, new systemic exposure data has also been shared for delgocitinib cream at the meeting.2 “The data unveiled today further ...
